Name : Deepa Sharma(38Y/F)

Date : 20 Feb 2025

Test Asked : Hs360

Report Status: Complete Report

PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY : SELF
235/60 MARIYANA KRISHNA PURAM MEERUT
TEST ASKED : HS360

Report Availability Summary

Note: Please refer to the table below for status of your tests.

15 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

HS360 Ready

BILIRUBIN -DIRECT Ready

PERIPHERAL BLOOD SMEAR (PBS) Ready

HEMOGRAM - 6 PART (DIFF) Ready

CREATININE - SERUM Ready

IRON DEFICIENCY PROFILE Ready

VITAMIN B-12 Ready

BLOOD GROUPING AND RH TYPING Ready

BILIRUBIN - TOTAL Ready

URIC ACID Ready

T3-T4-USTSH Ready

FASTING BLOOD SUGAR(GLUCOSE) Ready

COMPLETE URINE ANALYSIS Ready

ALANINE TRANSAMINASE (SGPT) Ready

BLOOD UREA Ready

ASPARTATE AMINOTRANSFERASE (SGOT ) Ready

PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY : SELF 235/60 MARIYANA KRISHNA PURAM MEERUT
TEST ASKED : HS360

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
COMPLETE HEMOGRAM
EOSINOPHILS 0.9 % 1-6
HEMATOCRIT(PCV) 33.1 % 36.0-46.0
HEMOGLOBIN 9.7 g/dL 12.0-15.0
LYMPHOCYTE 48 % 20-40
LYMPHOCYTES - ABSOLUTE COUNT 3.54 X 10³ / µL 1.0-3.0
MEAN [Link](MCHC) 29.3 g/dL 31.5-34.5
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 23.5 pq 27.0-32.0
MEAN CORPUSCULAR VOLUME(MCV) 80.1 fL 83.0-101.0
MEAN PLATELET VOLUME(MPV) 12.6 fL 6.5-12
PLATELET DISTRIBUTION WIDTH(PDW) 18.6 fL 9.6-15.2
PLATELET TO LARGE CELL RATIO(PLCR) 48.3 % 19.7-42.4
PLATELETCRIT(PCT) 0.4 % 0.19-0.39
RED CELL DISTRIBUTION WIDTH (RDW-CV) 16.9 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 48.6 fL 39.0-46.0
IRON DEFICIENCY
% TRANSFERRIN SATURATION 5 % 13 - 45
IRON 25 µg/dL 50 - 170
[Link]-BINDING CAPACITY(UIBC) 465.41 µg/dL 162 - 368
LIVER
ALANINE TRANSAMINASE (SGPT) 58.75 U/L < 34
ASPARTATE AMINOTRANSFERASE (SGOT ) 34.95 U/L < 31
THYROID
TSH - ULTRASENSITIVE 10.3 µIU/mL 0.54-5.30

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY : SELF 235/60 MARIYANA KRISHNA PURAM MEERUT

TEST ASKED : HS360

TEST NAME TECHNOLOGY VALUE

BLOOD GROUPING AGGLUTINATION O

RH TYPING AGGLUTINATION POSITIVE

Method:- Processed on fully automated Matrix Automax analyser based on gel column agglutination technology.

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 21:03
Report Released on (RRT) : 20 Feb 2025 22:37
Sample Type : EDTA Whole Blood
Dr Saakshi Mittal MD(Path)
Labcode : 2002043914/DS794
Barcode : DB524290 Page : 1 of 14
Scan QR code to verify authenticity of reported results; active for 30 days from release time.
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY : SELF 235/60 MARIYANA KRISHNA PURAM MEERUT

TEST ASKED : HS360

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 9.7 g/dL 12.0-15.0
Hematocrit (PCV) CPH Detection 33.1 % 36.0-46.0
Total RBC HF & EI 4.13 X 10^6/µL 3.8-4.8
Mean Corpuscular Volume (MCV) Calculated 80.1 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 23.5 pq 27.0-32.0
Mean [Link]. Conc (MCHC) Calculated 29.3 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 48.6 fL 39.0-46.0
Red Cell Distribution Width (RDW - CV) Calculated 16.9 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 327.8 - *Refer Note below
MENTZER INDEX Calculated 19.4 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 7.37 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 46 % 40-80
Lymphocytes Percentage Flow Cytometry 48 % 20-40
Monocytes Percentage Flow Cytometry 4.5 % 2-10
Eosinophils Percentage Flow Cytometry 0.9 % 1-6
Basophils Percentage Flow Cytometry 0.3 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0.0-0.4
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 3.39 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 3.54 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.33 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.02 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.07 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.02 X 10³ / µL 0.0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 312 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 12.6 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 18.6 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 48.3 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.4 % 0.19-0.39
Remarks : Alert!!! RBCs:Mild anisopoikilocytosis. Predominantly normocytic normochromic with microcytes & ovalocytes. Platelets:Appear adequate in
smear.
*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 21:03

Report Released on (RRT) : 20 Feb 2025 22:37

Sample Type : EDTA Whole Blood
Labcode : 2002043914/DS794 Dr Saakshi Mittal MD(Path)
Barcode : DB524290 Page : 2 of 14
 PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY 235/60 MARIYANA KRISHNA PURAM MEERUT
: SELF
TEST ASKED : HS360

:
TEST NAME METHOD

PERIPHERAL BLOOD SMEAR (PBS) MICROSCOPY

RBCs : Mild anisopoikilocytosis. Predominantly normocytic normochromic with microcytes & ovalocytes.

WBCs : Total count normal with normal morphology on smear.

PLATELET : Appear adequate on smear with normal morphology.

CLINICAL REMARKS : Anemia, Clinical correlation.

TECHNOLOGY : MICROSCOPY

Please correlate with clinical conditions

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 21:03
Report Released on (RRT) : 20 Feb 2025 22:37
Sample Type : EDTA Whole Blood
Dr Saakshi Mittal MD(Path)
Labcode : 2002043914/DS794
Barcode : DB524290 Page : 3 of 14
PROCESSED AT :
Thyrocare
D-79, 3rd floor, sector-63,
gautam budh nagar,
Noida, UP-201301.

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY : SELF 235/60 MARIYANA KRISHNA PURAM MEERUT

TEST ASKED : HS360

TEST NAME TECHNOLOGY VALUE UNITS

VITAMIN B-12 E.C.L.I.A 348 pg/mL
Bio. Ref. Interval. :-

Normal: 197-771 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat,
eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin
sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic
anemias. For diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical
examination and other findings.

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Kit Validation Reference : Thomas [Link] laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st
Edition,TH Books-Verl-Ges,1998:424-431

Please correlate with clinical conditions.

Method:- Fully Automated Electrochemiluminescence Compititive Immunoassay

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 16:10
Report Released on (RRT) : 20 Feb 2025 19:07
Sample Type : SERUM
Dr Eesha Gupta MD(Path)
Labcode : 2002090059/DS794
Barcode : DB987661 Page : 4 of 14
PROCESSED AT :
Thyrocare
D-79, 3rd floor, sector-63,
gautam budh nagar,
Noida, UP-201301.

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY 235/60 MARIYANA KRISHNA PURAM MEERUT
: SELF
TEST ASKED : HS360

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 25 µg/dL

Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170
Method : Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 490 µg/dL

Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : Spectrophotometric Assay

% TRANSFERRIN SATURATION CALCULATED 5 %

Bio. Ref. Interval. :
13 - 45
Method : Derived from IRON and TIBC values
[Link]-BINDING PHOTOMETRY 465.41 µg/dL
CAPACITY(UIBC)
Bio. Ref. Interval. :
162 - 368
Method : SPECTROPHOTOMETRIC ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 16:10

Report Released on (RRT) : 20 Feb 2025 19:07
Sample Type : SERUM
Labcode : 2002090059/DS794 Dr Eesha Gupta MD(Path)
Barcode : DB987661
Page : 5 of 14
PROCESSED AT :
Thyrocare
D-79, 3rd floor, sector-63,
gautam budh nagar,
Noida, UP-201301.

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY 235/60 MARIYANA KRISHNA PURAM MEERUT
: SELF
TEST ASKED : HS360

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

SGOT / SGPT RATIO CALCULATED 0.59 Ratio <2
BILIRUBIN -DIRECT PHOTOMETRY 0.08 mg/dL < 0.3
BILIRUBIN - TOTAL PHOTOMETRY 0.51 mg/dL 0.3-1.2
BILIRUBIN (INDIRECT) CALCULATED 0.43 mg/dL 0-0.9
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 34.95 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 58.75 U/L < 34
Please correlate with clinical conditions.

Method :
OT/PT - Derived from SGOT and SGPT values.
BILD - Vanadate Oxidation
BILT - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 16:10
Report Released on (RRT) : 20 Feb 2025 19:07
Sample Type : SERUM
Labcode : 2002090059/DS794 Dr Eesha Gupta MD(Path)

Barcode : DB987661 Page : 6 of 14

PROCESSED AT :
Thyrocare
D-79, 3rd floor, sector-63,
gautam budh nagar,
Noida, UP-201301.

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY : SELF 235/60 MARIYANA KRISHNA PURAM MEERUT

TEST ASKED : HS360

TEST NAME TECHNOLOGY VALUE UNITS

CREATININE - SERUM PHOTOMETRY 0.59 mg/dL
Bio. Ref. Interval. :-

Male : 0.72 -1.18 mg/dL

Female: 0.55 - 1.02 mg/dL

Clinical Significance :
The significance of a single creatinine value must be interpreted in light of the patients muscle mass. A patient with a greater
muscle mass will have a higher creatinine concentration. The trend of serum creatinine concentrations over time is more important
than absolute creatinine concentration. Serum creatinine concentrations may increase when an ACE inhibitor (ACEI) is taken. The
assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic.

Please correlate with clinical conditions.

Method:- Creatinine Enzymatic Method

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 16:10
Report Released on (RRT) : 20 Feb 2025 19:07
Sample Type : SERUM
Dr Eesha Gupta MD(Path)
Labcode : 2002090059/DS794
Barcode : DB987661 Page : 7 of 14
 PROCESSED AT :
Thyrocare
D-79, 3rd floor, sector-63,
gautam budh nagar,
Noida, UP-201301.

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

235/60 MARIYANA KRISHNA PURAM MEERUT
REF. BY : SELF

TEST ASKED : HS360

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 130 ng/dL 80-200
TOTAL THYROXINE (T4) E.C.L.I.A 6.95 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 10.3 µIU/mL 0.54-5.30

Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay

USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay
Pregnancy reference ranges for TSH/USTSH :
Trimester || T3 (ng/dl) || T4 (µg/dl) || TSH/USTSH (µIU/ml)
1st || 83.9-196.6 || 4.4-11.5 || 0.1-2.5
2nd || 86.1-217.4 || 4.9-12.2 || 0.2-3.0
3rd || 79.9-186 || 5.1-13.2 || 0.3-3.5
References :
1. Carol Devilia, C I Parhon. First Trimester Pregnancy ranges for Serum TSH and Thyroid Tumor reclassified as
Benign. Acta Endocrinol. 2016; 12(2) : 242 - 243
2. Kulhari K, Negi R, Kalra DK et al. Establishing Trimester specific Reference ranges for thyroid hormones in Indian
women with normal pregnancy : New light through old window. Indian Journal of Contemporary medical research.
2019; 6(4)

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 16:10
Report Released on (RRT) : 20 Feb 2025 19:07
Sample Type : SERUM
Labcode : 2002090059/DS794 Dr Eesha Gupta MD(Path)
Barcode : DB987661 Page : 8 of 14
PROCESSED AT :
Thyrocare
D-79, 3rd floor, sector-63,
gautam budh nagar,
Noida, UP-201301.

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY : SELF 235/60 MARIYANA KRISHNA PURAM MEERUT

TEST ASKED : HS360

TEST NAME TECHNOLOGY VALUE UNITS

BLOOD UREA PHOTOMETRY 21.2 mg/dL
Bio. Ref. Interval. :-

ADULT 17 - 43
NEWBORN 8.4 - 25.8
INFANT/CHILD 10.8 - 38.4

CLINICAL SIGNIFICANCE :
Urea is Nitrogenous waste product formed after protein breakdown. Rise in Urea levels leads to Uremia which may cause Kidney
failure. Urea levels may be elevated due to renal causes such as acute glomerulonephritis, chronic nephritis, polycystic kidney,
tubular necrosis and nephrosclerosis.

Please correlate with clinical conditions.

Method:- KINETIC UV ASSAY.

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 16:10
Report Released on (RRT) : 20 Feb 2025 19:07
Sample Type : SERUM
Dr Eesha Gupta MD(Path)
Labcode : 2002090059/DS794
Barcode : DB987661 Page : 9 of 14
PROCESSED AT :
Thyrocare
D-79, 3rd floor, sector-63,
gautam budh nagar,
Noida, UP-201301.

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY 235/60 MARIYANA KRISHNA PURAM MEERUT
: SELF
TEST ASKED : HS360

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

URIC ACID PHOTOMETRY 3.8 mg/dL 3.2 - 6.1
Please correlate with clinical conditions.

Method :
URIC - Uricase / Peroxidase Method

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 16:10
Report Released on (RRT) : 20 Feb 2025 19:07
Sample Type : SERUM
Labcode : 2002090059/DS794 Dr Eesha Gupta MD(Path)

Barcode : DB987661 Page : 10 of 14

PROCESSED AT :
Thyrocare
D-79, 3rd floor, sector-63,
gautam budh nagar,
Noida, UP-201301.

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY : SELF 235/60 MARIYANA KRISHNA PURAM MEERUT

TEST ASKED : HS360

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 118 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- 2021 CKD EPI Creatinine Equation

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 16:10
Report Released on (RRT) : 20 Feb 2025 19:07
Sample Type : SERUM
Dr Eesha Gupta MD(Path)
Labcode : 2002090059/DS794
Barcode : DB987661 Page : 11 of 14
PROCESSED AT :
Thyrocare
D-79, 3rd floor, sector-63,
gautam budh nagar,
Noida, UP-201301.

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

235/60 MARIYANA KRISHNA PURAM MEERUT
REF. BY : SELF
TEST ASKED : HS360

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

Complete Urinogram
Physical Examination
VOLUME Visual Determination 3 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change < 1.003 - 1.003-1.030
PH pH indicator 6 - 5-8
Chemical Examination
URINARY PROTEIN PEI ABSENT mg/dL Absent
URINARY GLUCOSE GOD-POD ABSENT mg/dL Absent
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
BILE SALT Hays sulphur ABSENT - Absent
BILE PIGMENT Ehrlich reaction ABSENT - Absent
URINE BLOOD Peroxidase reaction ABSENT - Absent
NITRITE Diazo coupling ABSENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
MUCUS Microscopy ABSENT - Absent
RED BLOOD CELLS Microscopy ABSENT cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5
EPITHELIAL CELLS Microscopy ABSENT cells/HPF 0-5
CASTS Microscopy ABSENT - Absent
CRYSTALS Microscopy ABSENT - Absent
BACTERIA Microscopy ABSENT - Absent
YEAST Microscopy ABSENT - Absent
PARASITE Microscopy ABSENT - Absent

(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 21 Feb 2025 02:23
Report Released on (RRT) : 21 Feb 2025 03:51
Sample Type : URINE
Dr Eesha Gupta MD(Path)
Labcode : 2002119658/DS794
Barcode : CZ263960 Page : 12 of 14
PROCESSED AT :
Thyrocare
D-79, 3rd floor, sector-63,
gautam budh nagar,
Noida, UP-201301.

NAME : DEEPA SHARMA(38Y/F) HOME COLLECTION :

REF. BY : SELF 235/60 MARIYANA KRISHNA PURAM MEERUT

TEST ASKED : HS360

TEST NAME TECHNOLOGY VALUE UNITS

FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 96.56 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Fasting Plasma Glucose (FPG)

Normal 70 to 100 mg/dl

Prediabetes 100 mg/dl to 125 mg/dl

Diabetes 126 mg/dl or higher

Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.
Please correlate with clinical conditions.
Method:- GOD-PAP METHOD

~~ End of report ~~

Sample Collected on (SCT) : 20 Feb 2025 07:18

Sample Received on (SRT) : 20 Feb 2025 16:12
Report Released on (RRT) : 20 Feb 2025 17:14
Sample Type : FLUORIDE PLASMA
Dr Eesha Gupta MD(Path)
Labcode : 2002090189/DS794
Barcode : DC489842 Page : 13 of 14
Scan QR code to verify authenticity of reported results; active for 30 days from release time.
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume: (a) any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report, (b) any claims
of any nature whatsoever arising from or relating to the performance of the requested tests as well as any claim for
indirect, incidental or consequential damages. The total liability, in any case, of Thyrocare shall not exceed the
total amount of invoice for the services provided and paid for.
v Thyrocare Discovery video link :- [Link]

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v [Link] - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints, clinical support or feedback, write to us at customersupport@[Link]
or call us on 022-3090 0000

+ T&C Apply, #As on 5th December 2024, *As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 14 of 14